479 related articles for article (PubMed ID: 14716740)
61. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
Int J Urol; 2004 Jul; 11(7):501-9. PubMed ID: 15242359
[TBL] [Abstract][Full Text] [Related]
62. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
Wilson MJ; Woodson M; Wiehr C; Reddy A; Sinha AA
Exp Mol Pathol; 2004 Aug; 77(1):7-17. PubMed ID: 15215045
[TBL] [Abstract][Full Text] [Related]
63. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
Nakai H; Yamanishi T; Yasuda K; Kitahara S; Suzuki T
Neurourol Urodyn; 2004; 23(7):618-22. PubMed ID: 15382181
[TBL] [Abstract][Full Text] [Related]
64. Prostatic elasticity: a new non-invasive parameter to assess bladder outlet obstruction caused by benign prostatic hyperplasia (a canine experiment).
Fu S; Zhang M; Wang Y; Li Q; Tang J
Urology; 2013 Nov; 82(5):1114-9. PubMed ID: 24242892
[TBL] [Abstract][Full Text] [Related]
65. [Uroflowmetry and its influence factors in benign prostate hyperplasia patients].
Zhong KB; Jiang XZ; Peng CY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):99-101, 120. PubMed ID: 15871201
[TBL] [Abstract][Full Text] [Related]
66. Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.
Yokoyama T; Kumon H; Nasu Y; Takamoto H; Watanabe T
Int J Urol; 2006 Jul; 13(7):932-8. PubMed ID: 16882058
[TBL] [Abstract][Full Text] [Related]
67. Transurethral incision of the bladder neck using KTP in the treatment of bladder neck obstruction in women.
Fu Q; Xu YM
Urol Int; 2009; 82(1):61-4. PubMed ID: 19172099
[TBL] [Abstract][Full Text] [Related]
68. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
Tanaka Y; Masumori N; Itoh N; Furuya S; Ogura H; Tsukamoto T
Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
[TBL] [Abstract][Full Text] [Related]
69. [Surgery (TUR-P) as a recommended initial treatment modality for the presented case].
Gotoh M
Hinyokika Kiyo; 2005 Sep; 51(9):603-8. PubMed ID: 16229373
[TBL] [Abstract][Full Text] [Related]
70. Urodynamic evaluation of patients with lower urinary tract symptoms and small prostate volume.
Gomes CM; Nunes RV; Araújo RM; Sacomani CR; Trigo-Rocha FE; Bruschini H; Srougi M
Urol Int; 2008; 81(2):129-34. PubMed ID: 18758208
[TBL] [Abstract][Full Text] [Related]
71. Urodynamic patterns of normal male micturition: influence of water consumption on urine production and detrusor function.
Schmidt F; Shin P; Jorgensen TM; Djurhuus JC; Constantinou CE
J Urol; 2002 Oct; 168(4 Pt 1):1458-63. PubMed ID: 12352417
[TBL] [Abstract][Full Text] [Related]
72. Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs.
Winter ML; Liehr JG
Toxicol Appl Pharmacol; 1996 Feb; 136(2):211-9. PubMed ID: 8619228
[TBL] [Abstract][Full Text] [Related]
73. [Symptoms and signs of benign prostate hypertrophy (BPH)].
Imai K; Kurokawa K; Sekihara T; Suzuki T; Yamanaka H; Takahashi H; Mashimo T; Takahashi O; Kitaura K; Saruki K
Hinyokika Kiyo; 1993 Jan; 39(1):15-22. PubMed ID: 7681620
[TBL] [Abstract][Full Text] [Related]
74. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
[TBL] [Abstract][Full Text] [Related]
75. [Effects of transurethral catheterization on uroflow rate in the pressure-flow study of patients with benign prostatic hyperplasia].
Zhao SC; Zheng SB; Tan WL; Mao XM; Zhang P; Huang ZM; Zhang HJ; Zuo Y
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):710-2. PubMed ID: 17918710
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of cervico-urethral obstruction with ambulatory pressure/flow studies: an alternative to conventional pressure/flow studies?
Perachino M; Puppo P
Arch Esp Urol; 1994 Nov; 47(9):849-56. PubMed ID: 7530940
[TBL] [Abstract][Full Text] [Related]
77. [Flutamide, an alternative for patients with benign prostatic hyperplasia (BPH) that cannot be treated with surgery].
Granados EA
Arch Esp Urol; 1998 Sep; 51(7):675-9. PubMed ID: 9807893
[TBL] [Abstract][Full Text] [Related]
78. Effects of photoselective vaporization of the prostate on urodynamics in patients with benign prostatic hyperplasia.
Seki N; Nomura H; Yamaguchi A; Naito S
J Urol; 2008 Sep; 180(3):1024-8; discussion 1028-9. PubMed ID: 18639299
[TBL] [Abstract][Full Text] [Related]
79. Benign prostatic hyperplasia. A review of diagnostic and treatment options.
Pfeiffer GM; Giacomarra M
Adv Nurse Pract; 1999 Apr; 7(4):31-6; quiz 37-8. PubMed ID: 10382383
[TBL] [Abstract][Full Text] [Related]
80. Bladder consequences of prostatic obstruction.
Mauroy B
Eur Urol; 1997; 32 Suppl 1():3-8. PubMed ID: 9218936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
